Maureen Smith

Maureen Smith is a citizen leader committed to evidence-based medicine and patient/citizen engagement in research. Her commitment stems from her lived experience with the health system subsequent to a rare disease diagnosis in childhood. Maureen was honoured to be a commissioner on the Global Evidence Commission on Evidence to Address Societal Challenges (2021-2024) and co-led the Citizen Leadership Group of the Commission’s Implementation Council. She is the co-convenor of Cochrane’s Co-Production Methods group and chaired Cochrane’s Consumer Network Executive from 2019-2024. She is involved in several global projects and advisory committees. In Canada, Maureen is a Director on Canada’s Drug Agency Board of Directors and an Officer of the Board of Directors of Ontario’s Strategy for Patient-Oriented Research (SPOR) SUPPORT Unit. She is a Principal Knowledge User of SPOR’s Evidence Alliance. Maureen is a patient member on the Ontario Committee to Evaluate Drugs since 2014 and the Ontario Health Technology Advisory Committee since 2016.